Abstract:Fedotozine, a kappa opioid agonist, reverses digestive ileus caused by acetic acid (AA)-induced visceral pain in rats. The aims of this study were: to map, in conscious rats, central pathways activated by AA using Fos as a marker of neuronal activation; to characterize primary afferent fibres involved in this activation; and to investigate the effect of fedotozine on AA-induced Fos expression. AA (0.6%; 10 mL kg-1) was injected i.p. in conscious rats either untreated; pretreated 14 days before with capsaicin; … Show more
“…Because induction of c-FOS expression is widely used as an index of nociception and activation of afferent pathways (Bonaz et al, 2000), our data support the notion that H 2 S functions as a neuromodulator that participates in the inhibitory modulation of visceral nociception in the CNS.…”
Hydrogen sulfide (H 2 S) functions as a neuromodulator, but whether it modulates visceral perception and pain is unknown. Cystathionine -synthase (CBS) and cystathionine-␥-lyase (CSE) mediate enzymatic generation of H 2 S in mammalian cells. Here we have investigated the role of H 2 S in modulating nociception to colorectal distension, a model that mimics some features of the irritable bowel syndrome. Four graded (0.4 -1.6 ml of water) colorectal distensions (CRDs) were produced in conscious rats (healthy and postcolitic), and rectal nociception was assessed by measuring the behavioral response during CRD. Healthy rats were administered with sodium hydrogen sulfide (NaHS) (as a source of H 2 S), L-cysteine, or vehicle. In a second model, we investigated nociception to CRD in rats recovering from a chemically induced acute colitis. We found that CBS and CSE are expressed in the colon and spinal cord.Treating rats with NaHS resulted in a dose-dependent attenuation of CRD-induced nociception with the maximal effect at 60 mol/kg (p Ͻ 0.05). Administration of L-cysteine, a CSE/CBS substrate, reduced rectal sensitivity to CRD (p Ͻ 0.05). NaHSinduced antinociception was reversed by glibenclamide, a ATP-sensitive K ϩ (K ATP ) channel inhibitor, and N -nitro-L-arginine methyl ester hydrochloride (L-NAME), a nitric-oxide (NO) synthase inhibitor. The antinociceptive effect of NaHS was maintained during the resolution of colon inflammation induced by intrarectal administration of a chemical irritant. In summary, these data show that H 2 S inhibits nociception induced by CRD in both healthy and postcolitic rats. This effect is mediated by K ATP channels and NO. H 2 S-releasing drugs might be beneficial in treating painful intestinal disorders.
“…Because induction of c-FOS expression is widely used as an index of nociception and activation of afferent pathways (Bonaz et al, 2000), our data support the notion that H 2 S functions as a neuromodulator that participates in the inhibitory modulation of visceral nociception in the CNS.…”
Hydrogen sulfide (H 2 S) functions as a neuromodulator, but whether it modulates visceral perception and pain is unknown. Cystathionine -synthase (CBS) and cystathionine-␥-lyase (CSE) mediate enzymatic generation of H 2 S in mammalian cells. Here we have investigated the role of H 2 S in modulating nociception to colorectal distension, a model that mimics some features of the irritable bowel syndrome. Four graded (0.4 -1.6 ml of water) colorectal distensions (CRDs) were produced in conscious rats (healthy and postcolitic), and rectal nociception was assessed by measuring the behavioral response during CRD. Healthy rats were administered with sodium hydrogen sulfide (NaHS) (as a source of H 2 S), L-cysteine, or vehicle. In a second model, we investigated nociception to CRD in rats recovering from a chemically induced acute colitis. We found that CBS and CSE are expressed in the colon and spinal cord.Treating rats with NaHS resulted in a dose-dependent attenuation of CRD-induced nociception with the maximal effect at 60 mol/kg (p Ͻ 0.05). Administration of L-cysteine, a CSE/CBS substrate, reduced rectal sensitivity to CRD (p Ͻ 0.05). NaHSinduced antinociception was reversed by glibenclamide, a ATP-sensitive K ϩ (K ATP ) channel inhibitor, and N -nitro-L-arginine methyl ester hydrochloride (L-NAME), a nitric-oxide (NO) synthase inhibitor. The antinociceptive effect of NaHS was maintained during the resolution of colon inflammation induced by intrarectal administration of a chemical irritant. In summary, these data show that H 2 S inhibits nociception induced by CRD in both healthy and postcolitic rats. This effect is mediated by K ATP channels and NO. H 2 S-releasing drugs might be beneficial in treating painful intestinal disorders.
“…In animal models of acute (Bonaz et al, 2000) and chronic (Julia et al, 1995) inflammation, abnormal pain responses to CRD have been observed, demonstrating that inflammation induces both hyperalgesia and allodynia that persist when local inflammation is partially or totally resolved. Human studies in patients with ulcerative colitis and Crohn's disease (Bernstein et al, 1996;Chang et al, 2000) and IBS (Collins et al, 2001) have confirmed that colonic inflammation modulates colonic neural afferents.…”
H 2 S functions as a neuromodulator and exerts anti-inflammatory activities. Recent data indicate that irritable bowel syndrome (IBS) is linked to inflammation of the gastrointestinal tract. In this study, we have investigated the role of a novel H 2 S-releasing derivative of mesalamine (5-amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester, ATB-429) in modulating nociception to colorectal distension (CRD), a model that mimics some features of IBS, in healthy and postcolitic rats. Four graded (0.4 -1.6 ml of water) CRDs were produced in conscious rats, and colorectal sensitivity and pain were assessed by measuring the abdominal withdrawal response and spinal c-Fos expression. In healthy rats, ATB-429 dose dependently (25, 50, or 100 mg/kg) attenuated CRD-induced hypersensitivity and significantly inhibited CRD-induced overexpression of spinal c-FOS mRNA, whereas mesalamine had no effect. ATB-429-induced antinociception was reversed by glibenclamide, a ATP-sensitive K ϩ (K ATP ) channel inhibitor. The antinociceptive effect of ATB-429 was maintained in a rodent model of postinflammatory hypersensitivity (4 weeks after colitis induction). At a dose of 100 mg/kg, ATB-429 reversed the allodynic response caused by CRD in postcolitic rats. Colonic cyclooxygenase-2 and interkeukin-1 mRNA and spinal c-FOS mRNA expression were significantly down-regulated by ATB-429, but not by mesalamine. ATB-429, but not mesalamine, increased blood concentrations of H 2 S in both healthy and postcolitic rats. Taken together, these data suggest that ATB-429 inhibits hypersensitivity induced by CRD in both healthy and postcolitic, allodynic rats by a K ATP channel-mediated mechanism. This study provides evidence that H 2 S-releasing drugs might have beneficial effects in the treatment of painful intestinal disorders.
“…Fos, the protein product of the immediate early gene c-fos is a sensitive marker of neuronal activation classically used to localize 3 V. Sinniger et al spinal cord neurons responsive to acute stimuli of somatic or visceral origin (Menetrey et al, 1989;Hunt et al, 1987;Herdegen et al, 1991;Traub et al, 1992Traub et al, , 1993. Using the model of somatovisceral pain, we have previously shown that, fedotozine, a kappa-opioid receptor agonist known to improve abdominal symptoms in IBS patients (Dapoigny et al, 1995;Delvaux et al, 1999), has an antinociceptive effect and prevents AA-induced Fos expression in the thoraco-lumbar spinal cord in rats through a peripheral action on visceral afferents (Bonaz et al, 2000).…”
Section: Intracolonic (Ic) Instillation Of Trinitrobenzenesulfonic Acmentioning
confidence: 99%
“…Somato-visceral pain was assessed by counting abdominal contractions (Koster et al, 1959;Giamberardino et al, 1995;Bonaz et al, 2000) for 60 minutes, by periods of 10 min, following the ip injection of AA, classically described as the writhing test (Koster et al, 1959). Abdominal contractions consisted of the contraction of the flank muscles associated with inward movements of the hindlimb or with whole body stretching (Giamberardino et al, 1995).…”
“…Somato-visceral pain was induced in conscious rats (n=5) with ip injection of 0.6% AA (10 ml/kg) in the right lower quadrant of the abdomen as previously described (Bonaz et al, 2000).…”
To cite this version:Valérie Sinniger, Patrick Mouchet, Bruno Bonaz. Effect of nor-trimebutine on neuronal activation induced by a noxious stimulus or an acute colonic inflammation in the rat.. Life Sciences, Elsevier, 2005, 77 (23)
EFFECT OF NOR-TRIMEBUTINE ON NEURONAL ACTIVATION INDUCED BY A NOXIOUS STIMULUS OR AN ACUTE COLONIC INFLAMMATION IN THE RATValérie Sinniger(1,2), Patrick Mouchet (1), and Bruno Bonaz (1,2)
ABSTRACTNor-trimebutine is the main metabolite of trimebutine which is used in the treatment of patients with irritable bowel syndrome. Nor-trimebutine has a blocking activity on sodium channel and a potent local anaesthetic effect. These properties were used to investigate the effect of nortrimebutine on spinal neuronal activation induced by models of noxious somato-visceral stimulus and acute colonic inflammation. Nor-trimebutine was administered subcutaneously in rats 30 min
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.